Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. Mohamed, M. A. Hoda, C. Pirker, P. Heffeter, B. Ghanim, B. Hegedus, W. Klepetko, W. Berger (Austria). Effects of mTOR Inhibition in malignant mesothelioma. Eur Respir J 2010; 36: Suppl. 54, 3855

Member's Comments

No comment yet.

Related content which might interest you: Dissecting the mTOR pathway in malignant pleural mesothelioma Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology Year: 2010 Antitumor activity of MEK and PI3K inhibitors in malignant pleural mesothelioma Source: Annual Congress 2011 - Treatment options and tumour biology of malignant pleural mesothelioma Year: 2011 Inhibition of phosphatidylinositol 3-kinase and mitogen-activated protein kinase kinase prevents malignant pleural mesothelioma cell growth Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology Year: 2010 mTOR inhibition blocks tumor growth and pleural fluid accumulation in experimental murine mesothelioma Source: Annual Congress 2011 - Treatment options and tumour biology of malignant pleural mesothelioma Year: 2011 All-trans-retinoic acid inhibits tumor growth of malignant pleural mesothelioma in mice Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology Year: 2010 Proliferative intercellular signalling pathway in human malignant mesothelioma cells Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology Year: 2010 The inhibitory effect of PI3k inhibitor and MEK inhibitor on malignant pleural mesothelioma cell growth Source: Annual Congress 2009 - Pleural and mediastinal diseases Year: 2009 MTH-1 inhibition retards mesothelioma progression Source: International Congress 2017 – Pleural disease and mesothelioma: from the bench to the bedside Year: 2017 The regulatory effect of microRNAs on STAT signaling in malignant mesothelioma Source: Annual Congress 2011 - Treatment options and tumour biology of malignant pleural mesothelioma Year: 2011 Novel Synthetic lignan reduces asbestos-induced damage in human pleural mesothelial cells-Potential clinical usefulness in inhibiting pleural malignant mesothelioma Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 Multimodality treatment of malignant pleural mesothelioma Source: Annual Congress 2011 - Treatment options and tumour biology of malignant pleural mesothelioma Year: 2011 Targeting of CSF1R abrogates Lewis Lung adenocarcinoma-induced malignant pleural effusion Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management Year: 2018 All-trans-retinoic acid inhibits tumour growth of malignant pleural mesothelioma in mice Source: Eur Respir J 2009; 34: 1159-1167 Year: 2009 Effect of asbestos on gene expression of tight junctions components in malignant pleural mesothelioma Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 Impact of angiopoietin-1 in mesothelioma progression Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013 Effects of cisplatin and pemetrexed on 3D phenotypes of benign mesothelial and malignant pleural mesothelioma cells Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018 Late Breaking Abstract - Anaplastic Lymphoma Kinase inhibition as an effective treatment strategy against the enhanced lung carcinogenesis and cancer angiogenesis related to decreased PTPRZ1 expression Source: Virtual Congress 2020 – Biological aspects of lung cancer Year: 2020 Epithelial-to-mesenchymal transition in malignant mesothelioma Source: Annual Congress 2011 - Treatment options and tumour biology of malignant pleural mesothelioma Year: 2011 ADAM10 membrane-bound protease mediates malignant pleural mesothelioma invasiveness Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management Year: 2018 Effects of 2-Deoxy-glucose with Cisplatin-Pemetrexed in mesothelioma sphere formation. Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management Year: 2018